Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M12,500Revenue (TTM) $M924Net Margin (%)-20.5Altman Z-Score5.3
Enterprise Value $M12,712EPS (TTM) $-1.2Operating Margin %-13.6Piotroski F-Score2
P/E(ttm)--Beneish M-Score-2.3Pre-tax Margin (%)-18.3Higher ROA y-yY
Price/Book5.510-y EBITDA Growth Rate %--Quick Ratio1.8Cash flow > EarningsN
Price/Sales13.45-y EBITDA Growth Rate %--Current Ratio2.6Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-5.2Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-8.1Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M162ROIC % (ttm)-6.3Gross Margin Increase y-yN

Gurus Latest Trades with BMRN

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
BMRNJoel Greenblatt 2015-06-30 Sold Out $112.05 - $140
($123.93)
$ 77.01-38%Sold Out0
BMRNJoel Greenblatt 2015-03-31 Buy $90.28 - $129.14
($105.95)
$ 77.01-27%New holding4,195
BMRNJoel Greenblatt 2014-12-31 Sold Out $67.27 - $94.19
($83.42)
$ 77.01-8%Sold Out0
BMRNJoel Greenblatt 2014-09-30 Buy $55.78 - $73
($65.82)
$ 77.0117%New holding3,885
BMRNMeridian Funds 2013-06-30 Sold Out -0.09%$54.72 - $70.3
($62.32)
$ 77.0124%Sold Out0
BMRNMeridian Funds 2013-03-31 Reduce-0.17%$49.2 - $62.39
($56.51)
$ 77.0136%Reduce -69.03%40,700
BMRNMeridian Funds 2012-12-31 Reduce-0.3%$36.78 - $50.17
($45.59)
$ 77.0169%Reduce -60.99%131,400
BMRNGeorge Soros 2012-06-30 Sold Out -0.15%$32.53 - $38.87
($36.01)
$ 77.01114%Sold Out0
BMRNGeorge Soros 2012-03-31 Add0.11%$33.68 - $38.34
($32.99)
$ 77.01133%Add 300.00%300,000
BMRNGeorge Soros 2011-12-31 Reduce-0.05%$30.07 - $35.38
($32.81)
$ 77.01135%Reduce -57.14%75,000
BMRNGeorge Soros 2011-06-30 Add0.07%$24.93 - $28.455
($26.32)
$ 77.01193%Add 862.36%191,510
BMRNMeridian Funds 2011-03-31 Reduce-0.28%$23.46 - $28.29
($25.46)
$ 77.01202%Reduce -51.54%348,800
BMRNGeorge Soros 2011-03-31 Buy 0.01%$23.46 - $28.29
($25.46)
$ 77.01202%New holding19,900
BMRNGeorge Soros 2010-09-30 Sold Out -0.02%$18.24 - $23.09
($20.93)
$ 77.01268%Sold Out0
BMRNMeridian Funds 2010-03-31 Add0.13%$18.75 - $23.81
($20.92)
$ 77.01268%Add 20.83%795,900
BMRNGeorge Soros 2010-03-31 Add$18.75 - $23.81
($20.92)
$ 77.01268%Add 35.87%30,300
BMRNGeorge Soros 2009-12-31 Buy 0.01%$15.49 - $18.98
($17.17)
$ 77.01349%New holding22,300
BMRNMeridian Funds 2009-09-30 Buy 0.53%$13.86 - $18.33
($15.84)
$ 77.01386%New holding658,700
BMRNBill Gates 2009-06-30 Sold Out -0.02%$11.92 - $15.94
($13.79)
$ 77.01458%Sold Out0
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

BMRN is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


BMRN: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
LAWLIS V BRYANDirector 2016-06-20Sell550$82.77-6.96view
BIENAIME JEAN JACQUESCEO 2016-06-16Sell41,666$80.55-4.39view
SPIEGELMAN DANIEL KEVP, CFO 2016-06-06Sell1,649$89.14-13.61view
SPIEGELMAN DANIEL KEVP, CFO 2016-05-31Sell20,841$89.88-14.32view
FUCHS HENRY JEVP, Chief Medical Officer 2016-05-26Sell15,000$87.81-12.3view
SPIEGELMAN DANIEL KEVP, CFO 2016-05-23Sell3,769$87.07-11.55view
BAFFI ROBERTEVP, Technical Operations 2016-05-18Sell5,000$87.05-11.53view
Davis George EricEVP, General Counsel 2016-05-10Sell14,658$85.11-9.52view
BIENAIME JEAN JACQUESCEO 2016-05-05Sell50,000$80.15-3.92view
Ajer Jeffrey RobertEVP, Chief Commercial Officer 2016-05-03Sell415$86.03-10.48view

Press Releases about BMRN :

Quarterly/Annual Reports about BMRN:

News about BMRN:

Articles On GuruFocus.com
Spiros Segalas Buys McDonald's, Microsoft, Alibaba May 05 2016 
Kyle Bass Sells Stakes in 11 Health Care Companies Mar 01 2016 
J.P. Morgan’s 3 Biotechnology Picks Apr 14 2015 
You Can No Longer Ignore Biotech Feb 07 2014 
Weekly Top Insider Sells: AAPL, GILD, BMRN, and PCLN Nov 19 2012 
WEEKLY CFO SELLS HIGHLIGHT: VVUS, DIS, SNPS, TXRH, BMRN Mar 04 2012 
5 Resilient Biotech Stocks to Buy for 2012 Feb 28 2012 
Weekly CFO Sells Highlight: MSCC, BMRN, VAL, CUTR, REX, CIEN Oct 02 2011 
BioMarin Pharmaceutical Inc. Reports Operating Results (10-K) Feb 24 2011 
BioMarin Pharmaceutical Inc. (BMRN) CEO Jean Jacques Bienaime sells 1,000 Shares Dec 13 2010 

More From Other Websites
After Brexit, These Biotech Stocks Are Vulnerable To A Mighty Dollar Jun 24 2016
BioMarin Announces Acceptance of Late Breaking Abstract for BMN 270 at the World Federation of... Jun 20 2016
BioMarin Announces Acceptance of Late Breaking Abstract for BMN 270 at the World Federation of... Jun 20 2016
BioMarin Takeout Rumors Swirl, Industry Insiders Aren't Convinced Jun 17 2016
Why Traders Are Buzzing About MGM, Apple, and Three Other Companies Today Jun 17 2016
BioMarin Stock Stumbles On Trial Halt, But No New Issue Jun 16 2016
Why BioMarin (BMRN) Stock Is Lower Today Jun 16 2016
BioMarin: Overreaction? Jun 16 2016
The Zacks Analyst Blog Highlights: iShares Nasdaq Biotechnology, Biogen, Alexion Pharma, BioMarin... Jun 13 2016
4 Stocks That Crushed the Biotechnology ETF (IBB) This Week Jun 10 2016
BIOMARIN PHARMACEUTICAL INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders Jun 10 2016
BioMarin Pharmaceutical, Inc. – Value Analysis (NASDAQ:BMRN) : June 9, 2016 Jun 09 2016
BioMarin Pharmaceutical, Inc. breached its 50 day moving average in a Bearish Manner : BMRN-US :... Jun 08 2016
Sarepta Stock Up On New Twist In Muscular-Dystrophy Drug Saga Jun 07 2016
Sarepta Asked to Provide Dystrophin Data on Eteplirsen Jun 07 2016
Biotech: Is the Rally Real? Jun 02 2016
BioMarin Stock Slides After Muscular-Dystrophy Drug Shelved Jun 01 2016
BioMarin Announces Withdrawal of Market Authorization Application for Kyndrisa™ (drisapersen) in... Jun 01 2016
Why BioMarin's Bad News is Great for Sarepta Jun 01 2016
Stocks to Watch: Salesforce, Michael Kors, Lands' End, Alibaba Jun 01 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)